novel targeted therapies for the treatment of bpdcn
Published 18 hours ago • 25 plays • Length 2:57Download video MP4
Download video MP3
Similar videos
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
3:19
an overview of novel treatment approaches in tp53-mutated aml
-
2:25
novel ai model for personalized risk stratification & treatment in newly diagnosed multiple myeloma
-
1:58
novel myelofibrosis-associated anemia treatments in phase ii trials
-
2:33
novel immunotherapies in aml and insights into the future of the treatment landscape
-
1:34
managing adverse events with novel therapies in lower-risk mds
-
1:14
novel inducers of apoptosis in double-refractory cll cells
-
3:30
unmet needs in mf: managing anemia & improving the efficacy of first and second-line treatments
-
1:18:17
21/22 finals crash course series: haematology and oncology revision
-
3:36
how can i ensure my cll doesn’t progress to richter’s transformation?
-
4:03
novel technologies in multiple myeloma and how these are changing the field
-
2:44
novel bcma-targeting therapies to treat tce relapsed/refractory multiple myeloma
-
2:11
beat aml master trial: novel precision medicine approach in aml
-
10:01
novel targets in 2022
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
1:04
exciting updates in mf: novel targets and agents
-
2:07
phase i/ii study of edit-301, a novel gene-edited autologous hsc medicine, in patients with scd
-
2:33
identifying novel biomarkers and advancing the classification system in cll
-
5:25
how the aml treatment landscape is changing with the introduction of novel targeted agents
-
2:05
investigating mutation order in aml using single-cell sequencing
-
1:56
stellar: genomic sequencing of ctdna reveals additional driver mutations in richter's transformation